OSTEOBLASTS DIFFERENTIATED FROM MESENCHYMAL STEM CELLS AND COMPOSITION FOR TREATING BONE DISEASE COMPRISING SAME

    公开(公告)号:US20230248776A1

    公开(公告)日:2023-08-10

    申请号:US17918093

    申请日:2021-10-08

    Applicant: CEFO Co., Ltd.

    CPC classification number: A61K35/32 A61P19/08

    Abstract: The present invention relates to a method for differentiating mesenchymal stem cells into osteoblasts, a cell therapeutic agent for treating bone disease including osteoblasts differentiated by the method and a method for producing the same. In addition, the present invention relates to a method for treating bone disease, including the step of administering the osteoblasts obtained by the method to a patient with bone disease.
    The differentiation method according to the present invention can stably and rapidly differentiate mesenchymal stem cells into osteoblasts. The differentiated osteoblasts have excellent blood vessel-forming ability and excellent bone-forming ability. Accordingly, the method for differentiating stem cells into osteoblasts and the osteoblasts obtained by the method, according to the present invention, can be effectively used as a cell therapeutic agent or treatment method related to bone disease.

Patent Agency Ranking